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ScreeningforDown's syndrome
Professor Nicholas J Wald and others (8 October,
p 883) report a new screening test for Down's
syndrome with a higher detection rate and a lower
false positive rate than currently available tests,
which is likely to be welcomed by epidemiologists,
obstetricians, and prospective parents. But as
Drs Dian Donnai and Tony Andrews (8 October,
p 876) argue, the problems in introducing any new
screening test should not be underestimated. One
such problem is the effect upon women of receiv-
ing a false positive result. Although distress in
women who have been told that they have raised
maternal serum a fetoprotein concentrations
(indicating an increased riskofan open neural tube
defect) has been documented,' there has been no
study of the effects of screening for Down's syn-
drome. In a prospective study currently underway
we are studying the impact ofvarious prenatal test
results on women consecutively booked for ante-
natal care at this hospital. Forty two women had
abnormally low maternal serum (C fetoprotein
concentrations that weresubsequently shown tobe
false positive results. We report some initial find-
ings that illustrate the psychological impact of
receiving false positive results.
We report separately on women aged 38 and
over (who are routinely treated as being at extra
risk from the beginning of pregnancy and are
offered amniocentesis for chromosomal analysis in
this region) and women aged under 38 (a group
who are not encouraged to consider themselves
at increased risk of having a baby with Down's
syndrome), forwhom an abnormal maternal serum
concentration ofai fetoprotein is a new challenge to
the pregnancy. In the older group those with an
abnormal result show similar changes in anxiety at
the time ofthe result to those with a normal result.
Three weeks later when the results of any sub-
sequent tests have shown the result to be false they
were no more anxious than those with a normal
result. The results are quite different for younger
women receiving a false positive result: they show
much more anxiety both at the time of receiving
thetestresultandthreeweekslaterwhencompared
with women with normal results (figure). The
mean score for women aged less than 38 receiving
an abnormal result was 53 8 (SD 2 8), a score well
above normal (mean 35-1 (9 2)), and within the
range for patients with a diagnosis of general
anxiety disorder (mean 49 0 (11-6)).2
Inadequate understanding of a test and poor
preparation for potentially bad news are likely to
be two factors contributing to this increased dis-
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tress in younger women. Women do not have a
good understanding of such tests; in a previous
study 39% of the women could not even identify
whether they had had blood taken to test for spina
bifida.' With adequate preparation the impact of a
positive test result is likely to be reduced, as is
evident in the precounselling of those using HIV
antibody screening services.' An association
between maternal stress and obstetric outcome has
been documented.' Before introducing any new
screening tests into routine obstetric care we need
to ensure adequate counselling to minimise the
distress now known to arise for women undergoing
such tests.
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